BM‐MSC vs no treatment
Overall survival · people with probable or definite amyotrophic lateral sclerosis/motor neuron disease (treated with riluzole)
BM‐MSC showed no clear difference in overall survival compared with no treatment (low certainty).
1 finding from 1 review
- Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease 2019 · Cochrane Headline outcomes onlyRR 1.07 [0.94, 1.22]1 study · 64 participantsLow